Therapeutics/Diagnostics

Top Story

Rebiotix completes enrollment for phase 3 trial of C. diff microbiota therapy

February 14, 2020
Meeting News

Stelara dose escalation effective, safe in luminal, perianal Crohn’s disease

February 4, 2020
AUSTIN, Texas — Real-world dose escalation of Stelara was safe and effective in patients with perianal Crohn’s disease, according to data presented at…
Meeting News

Chronic inflammatory disease expenditures nearly double over last 2 decades

February 4, 2020
AUSTIN, Texas — The overall health care cost of caring for patients with inflammatory bowel disease has increased at a rapid rate over the last 20 years, according…
Meeting NewsVideo

VIDEO: Start with the ‘basics’ when positioning therapies for UC

January 29, 2020
AUSTIN, Texas — In this exclusive video from Crohn’s & Colitis Congress, James Lindsay, PhD, FRCP, professor of inflammatory bowel disease at Barts and…
More Headlines »